Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19

LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

Shranjeno v:
Bibliografske podrobnosti
izdano v:Aliment Pharmacol Ther
Main Authors: Prentice, Ralley E., Tjandra, Doug, Garg, Mayur, Lubel, John S., Fourlanos, Spiros, Johnson, Doug, Al‐Ani, Aysha, Christensen, Britt
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Letters to the Editors
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537250/
https://ncbi.nlm.nih.gov/pubmed/33105980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.16063
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki